Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) – Sanofi EFC17236 MOBILIZE

Patient and caregiver smiling

If CIDP Is Affecting Your Life, This Study May Be an Option for You  

The Las Vegas Neurology Center along with Profound Research are enrolling a Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) study that is assessing an investigational medication to see if it helps improve functional disability. 

To be eligible to participate, you must: 

  • Be at least 18 years of age 
  • Be diagnosed or possibly have CIDP 
  • Be non-responsive to immunoglobulin or corticosteroid therapy 
  • Have an INCAT score of 2-9 
  • Not have Guillain-Barré syndrome or diabetic neuropathy 

Additional criteria apply. 

Qualified participants will receive: 

  • Study-related care and study medication at no cost 
  • Financial compensation for time and travel expenses 

Number of visits and duration of study: 

  • 17 clinic visits over 42 weeks and 5 additional phone call visits  

Call us at 725-226-5989 or complete the form and our team will reach out soon to help determine your eligibility.

Trial Interest Form